209 related articles for article (PubMed ID: 27397486)
1. Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review.
Lim MS; Enjeti AK
Crit Rev Oncol Hematol; 2016 Sep; 105():92-9. PubMed ID: 27397486
[TBL] [Abstract][Full Text] [Related]
2. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
Campbell PM; Ippoliti C; Parmar S
J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
[TBL] [Abstract][Full Text] [Related]
3. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature.
Annibali O; Napolitano M; Avvisati G; Siragusa S
Crit Rev Oncol Hematol; 2018 Apr; 124():41-50. PubMed ID: 29548485
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
7. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
Labrador J; González-Rivero J; Monroy R; Lozano FS; López-Corral L; Caballero MD; Bastida JM; González-Porras JR
Thromb Res; 2016 Jun; 142():52-6. PubMed ID: 26922092
[TBL] [Abstract][Full Text] [Related]
8. Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism.
Pun H; Pang I; Leblanc K; Dhillon P; McEwan C; Patel P; Kumar R
J Oncol Pharm Pract; 2024 Jul; 30(5):823-829. PubMed ID: 37501557
[TBL] [Abstract][Full Text] [Related]
9. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
Al-Samkari H; Connors JM
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):71-79. PubMed ID: 31808892
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.
Kim S; Namba J; Goodman AM; Nguyen T; Saunders IM
J Oncol Pharm Pract; 2020 Mar; 26(2):351-360. PubMed ID: 31142232
[TBL] [Abstract][Full Text] [Related]
11. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.
Napolitano M; Saccullo G; Marietta M; Carpenedo M; Castaman G; Cerchiara E; Chistolini A; Contino L; De Stefano V; Falanga A; Federici AB; Rossi E; Santoro R; Siragusa S; ; ; De Stefano V; Falanga A; Tosetto A; Avvisati G; Carpenedo M; Federici AB; Marietta M; Napolitano M; Rossi E; Santoro C; Castaman G; Cerchiara E; Chistolini A; Contino L; Mazzucconi MG; Nichele I; Russo L; Santi R; Santoro RC; Siragusa S; Tagariello G
Blood Transfus; 2019 May; 17(3):171-180. PubMed ID: 30418130
[TBL] [Abstract][Full Text] [Related]
12. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
Kopolovic I; Lee AY; Wu C
Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
[TBL] [Abstract][Full Text] [Related]
13. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.
Figueroa R; Alfonso A; López-Picazo J; Gil-Bazo I; García-Mouriz A; Hermida J; Páramo JA; Lecumberri R
PLoS One; 2018; 13(8):e0200220. PubMed ID: 30071038
[TBL] [Abstract][Full Text] [Related]
14. Management of cancer-associated venous thromboembolism - a case-based practical approach.
Voigtlaender M; Langer F
Vasa; 2018 Feb; 47(2):77-89. PubMed ID: 29325495
[TBL] [Abstract][Full Text] [Related]
15. Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?
Buka RJ; Chandra D; Sutton DJ
Br J Haematol; 2021 Apr; 193(1):194-197. PubMed ID: 33618429
[No Abstract] [Full Text] [Related]
16. Direct oral anticoagulants in patients with hematologic malignancies.
Serrao A; Fiori L; Santoro C; De Luca ML; Ferretti A; De Luca G; Ligia S; Lapietra G; Mohamed S; Breccia M; Chistolini A
Hematol Oncol; 2020 Oct; 38(4):589-596. PubMed ID: 32588912
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
Ross JA; Miller MM; Rojas Hernandez CM
Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin.
Nicklaus MD; Ludwig SL; Kettle JK
J Oncol Pharm Pract; 2018 Apr; 24(3):185-189. PubMed ID: 29284351
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
